Markets.com Logo

ZLAB

$--
--%
1d
1w
1m

Analysis and statistics

  • Open
    33.7675$
  • Previous Close
    34.2797$
  • 52 Week Change
    26.30$
  • Day Range
    -0.51$
  • 52 Week High/Low
    18.04$ - 44.34$
  • Dividend Per Share
    --
  • Market cap
    3 914 M$
  • EPS
    -0.04
  • Beta
    1.033
  • Volume
    --

About

ZLAB.US represents shares of Zai Lab Limited, a biopharmaceutical company focused on discovering, developing, and commercializing innovative therapies to address unmet medical needs in China and globally. The company's portfolio includes a mix of internally discovered candidates and in-licensed products, with a focus on oncology, autoimmune, infectious disease, and neuroscience areas. Zai Lab aims to accelerate the approval and market access of potentially life-changing medicines for patients worldwide.

Iran's Hormuz Gambit: Leveraging a Chokepoint for Economic Leverage and Global Impact

Ava Grace|--

Gold Market Resilience: Navigating Sell-offs and Sustaining Bull Run

Noah Lee|--

Meta Platforms: Navigating Legal Headwinds and AI Opportunities for Investors

Liam James|--

US Stocks Poised for Potential Rebound Amidst Easing Geopolitical Tensions and Shifting Investor Positioning

Sophia Claire|--
UAE as Global Gold Powerhouse: Analyzing the 2026 Resilience of Dubai’s Gold Trading Ecosystem

UAE as Global Gold Powerhouse: Analyzing the 2026 Resilience of Dubai’s Gold Trading Ecosystem

Ghko B|--
Trade Desk (TTD) Analysis: Is the 2026 Tech Dip a Strategic Entry Point for UAE Investors?

Trade Desk (TTD) Analysis: Is the 2026 Tech Dip a Strategic Entry Point for UAE Investors?

Ghko B|--
Cryptocurrency-related stocks analysis: MicroStrategy (MSTR) stock, BMNR stock, Coinbase

Cryptocurrency-related stocks analysis: MicroStrategy (MSTR) stock, BMNR stock, Coinbase

Ghko B|--

Factors

Here's a breakdown of factors affecting ZLAB.US stock price: Clinical Trial Results: Positive or negative data from Zai Lab's clinical trials significantly impact investor sentiment.

Regulatory Approvals: FDA or other regulatory body decisions on Zai Lab's drug candidates are key price drivers.

Market Competition: Competitive landscape and the success of rival drugs influence Zai Lab's potential market share and valuation.

Partnerships and Collaborations: Strategic alliances with other pharmaceutical companies can boost Zai Lab's prospects and stock price.

Financial Performance: Zai Lab's revenue, expenses, and profitability directly affect investor confidence.

Broader Market Conditions: Overall economic trends and investor sentiment toward the biotech sector influence stock valuation.

Company News & Announcements: Major announcements related to new products, leadership changes, or strategic direction can impact investor confidence.

People Also Watch

Latest news

Ukraine Forges New Alliances in the Middle East, Leveraging Defense Expertise

Sophia Claire|--

US Reinforces Middle East Presence Amid Escalating Tensions with Iran

Noah Lee|--

Fed Policy Pivot: Inflation Risks Hint at Potential Rate Hikes, Shifting Market Expectations

Sophia Claire|--

Latest Education Articles

S&P 500, Nasdaq, Dow & Russell 2000: Important Technical Levels Traders Should Watch

S&P 500, Nasdaq, Dow & Russell 2000: Important Technical Levels Traders Should Watch

Ghko B|--
What is CCI strategy: What is the formula for Commodity Channel Index?

What is CCI strategy: What is the formula for Commodity Channel Index?

Ghko B|--
Relative Strength Index (RSI) in trading: RSI indicator buy and sell signals, RSI explained with examples

Relative Strength Index (RSI) in trading: RSI indicator buy and sell signals, RSI explained with examples

Ghko B|--